FCF Life Sciences Venture Capital Monitor – Europe 09/2021 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 09/2021”.

The Monitor is a monthly published overview of venture capital trends in the European Life Sciences sector.

As of the end of September 2021 we identify the following current VC trends in Europe:

  • In 2021, overall Life Sciences funding has reached EUR 9,955m so far
  • Top 5 Deals exceed EUR 190m each, largest transaction amounted to EUR 497m in CMR Surgical Ltd. (United Kingdom)
  • BlackRock (USA) still dominates the Top 5 Investors (by deal volume), followed by Fidelity Management & Research (USA) and Novo Holdings (Denmark)
  • The Biotechnology sector received 43% of the total investment volume (-7% points compared to the previous month)
  • Oncology dominates as the top indication

To access the full report, please click here.

By Dr. Mathias Schott, Sebastian Sommer and Alexander Kuhn

Share on linkedin
Share